NantHealth appoints Rao Haris Naseem as CEO; Patrick Soon-Shiong remains Chairman

NantHealth, Inc.

Dr. Rao Haris Naseem appointed CEO and board member effective September 7, 2023.
Founder Patrick Soon-Shiong steps down as CEO but continues as Chairman.
Base salary set at $35,568; eligible for discretionary bonus; option to purchase 1,000,000 shares subject to board approval.
Naseem's affiliate Summus Holdings purchased 3,846,154 shares ($1.5M) in a private placement closed August 30, 2023.
Employment is at-will; vesting of stock options accelerated 100% upon change in control.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Patrick Soon-Shiong

Chairman of the Board

NantHealth, Inc.

Effective: 2023-09-07
Successor: Rao Haris Naseem
Filed: September 13, 2023, 7:59 PM ET

In connection with Dr. Naseem’s appointment as CEO, Patrick Soon-Shiong, M.D. transitioned out of his role as CEO of the Company and will continue to serve as Chairman of the Board as of the Effective Date.

Appointed

Rao Haris Naseem

Chief Executive Officer

NantHealth, Inc.

Effective: 2023-09-07
Filed: September 13, 2023, 7:59 PM ET

On September 7, 2023, the Board of Directors (the “Board”) of NantHealth, Inc. (the “Company”) appointed Rao Haris Naseem, M.D., FACC, FHRS as the Company’s Chief Executive Officer (“CEO”) and a member of the Board, effective September 7, 2023 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick Soon-Shiong changed role as Chairman of the Board at NantHealth, Inc..

Action: transitioned out of CEO role
Role: Chairman of the Board

Exact text from the filing

In connection with Dr. Naseem’s appointment as CEO, Patrick Soon-Shiong, M.D. transitioned out of his role as CEO of the Company and will continue to serve as Chairman of the Board as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Rao Haris Naseem was appointed as Chief Executive Officer at NantHealth, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On September 7, 2023, the Board of Directors (the “Board”) of NantHealth, Inc. (the “Company”) appointed Rao Haris Naseem, M.D., FACC, FHRS as the Company’s Chief Executive Officer (“CEO”) and a member of the Board, effective September 7, 2023 (the “Effective Date”).

View on SEC.gov

Source: SEC EDGAR

accession 0001566469-23-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.